Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy

January 20, 2025 |  

Discover the key takeaways from OPEN Health’s latest whitepaper: “The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy.”

IRA whitepaper_OPEN Health

Discover the key takeaways from OPEN Health’s latest whitepaper The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy:

  • Review of President Trump’s healthcare policies during his first term: Attempts to repeal the Affordable Care Act (ACA), drug pricing initiatives, and Medicare and Medicaid policies.
  • A look into the future of the Inflation Reduction Act (IRA) and broader healthcare policy in the US: The potential impact of the incoming administration on the healthcare provisions of the IRA and other statements by President Trump focused on healthcare policy.

Read the full whitepaper to understand how these developments could influence healthcare decision-making and strategy. View the whitepaper here.

Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. Together we can unlock possibilities. For information about OPEN Health’s services and how we could support you, please get in touch. 

This content was provided by OPEN Health

Company Details

OPEN Health

OPEN Health

Email
Website

 Latest Content from  OPEN Health 

Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing

OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.

Spotlight interview: 15 minutes on the procurement function in pharma

Carwyn Jones, Senior Partner at OPEN Health, takes 15 minutes to answer some key questions on the procurement function in pharma.

Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era

The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to...

OPEN Health Medical Communications announces Group MD promotions and welcomes new Creative Director

OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee...

OPEN Health Graduates and the XP Support Group

During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...